SLC5A2 and chronic kidney disease: These findings support the established understanding that effective BP control is crucial to mitigating cardiovascular risk in CKD populations. Most interventions were associated with reductions in systolic BP, with agents such as RAAS inhibitors, SGLT2 inhibitors, and dietary supplements like pomegranate extract demonstrating modest but statistically significant effects in individual studies.